TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 16.54%90.17M | ---- | -44.68%77.37M | ---- | -17.31%139.87M | ---- | 14.76%169.15M | ---- | 33.17%147.4M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 20.62%-23.8M | ---- | 4.18%-29.98M | ---- | -15.14%-31.29M | ---- | -17.06%-27.17M | ---- | -52.31%-23.21M |
Attributable subsidiary (profit) loss | ---- | -12.65%4.49M | ---- | -54.89%5.15M | ---- | 377.44%11.41M | ---- | -39.60%2.39M | ---- | -65.01%3.96M |
Impairment and provisions: | ---- | 116.53%46.71M | ---- | 155.65%21.57M | ---- | -4,827.68%-38.77M | ---- | -98.90%820K | ---- | --74.64M |
-Impairmen of inventory (reversal) | ---- | 1,530.00%1.57M | ---- | -120.37%-110K | ---- | --540K | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 108.17%45.14M | ---- | --21.68M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | -4,893.54%-39.31M | ---- | -98.90%820K | ---- | --74.64M |
Revaluation surplus: | ---- | 554.44%13.47M | ---- | 14.78%-2.96M | ---- | -1,104.91%-3.48M | ---- | -84.00%346K | ---- | 2,784.00%2.16M |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---300K |
-Other fair value changes | ---- | 554.44%13.47M | ---- | 14.78%-2.96M | ---- | -1,104.91%-3.48M | ---- | -85.95%346K | ---- | 3,184.00%2.46M |
Asset sale loss (gain): | ---- | -5,109.30%-12.92M | ---- | 544.83%258K | ---- | -383.33%-58K | ---- | 99.85%-12K | ---- | -8,276.53%-8.01M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --240K | ---- | ---- | ---- | ---- | ---- | --5.7M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -566.67%-84K | ---- | 131.03%18K | ---- | -383.33%-58K | ---- | 91.61%-12K | ---- | -245.92%-143K |
-Loss (gain) from selling other assets | ---- | ---12.84M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.57M |
Depreciation and amortization: | ---- | 13.59%89.75M | ---- | 17.18%79.02M | ---- | 14.47%67.43M | ---- | 6.03%58.91M | ---- | 20.48%55.56M |
-Amortization of intangible assets | ---- | 52.54%8.91M | ---- | 1.13%5.84M | ---- | 5.37%5.77M | ---- | 8.13%5.48M | ---- | 31.92%5.07M |
Financial expense | ---- | -6.31%29.15M | ---- | 0.46%31.12M | ---- | 39.31%30.97M | ---- | 10.90%22.23M | ---- | 20.62%20.05M |
Unrealized exchange loss (gain) | ---- | -96.88%10K | ---- | 780.85%320K | ---- | 92.71%-47K | ---- | ---645K | ---- | ---- |
Special items | ---- | 51.64%-2.46M | ---- | 13.60%-5.08M | ---- | -22.85%-5.88M | ---- | 27.53%-4.78M | ---- | -150.40%-6.6M |
Operating profit before the change of operating capital | ---- | 32.69%234.58M | ---- | 3.88%176.78M | ---- | -23.08%170.17M | ---- | -16.81%221.24M | ---- | 45.52%265.94M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 1,044.06%24.75M | ---- | 127.55%2.16M | ---- | 68.30%-7.85M | ---- | -246.94%-24.77M | ---- | 267.62%16.85M |
Accounts receivable (increase)decrease | ---- | -5.30%-25.95M | ---- | -394.35%-24.65M | ---- | 301.13%8.37M | ---- | 97.55%-4.16M | ---- | -2,712.81%-169.78M |
Accounts payable increase (decrease) | ---- | 90.51%-10.75M | ---- | -442.77%-113.31M | ---- | -53.48%33.06M | ---- | 49.37%71.06M | ---- | 37.92%47.57M |
Special items for working capital changes | ---- | -127.73%-10.24M | ---- | 151.49%36.95M | ---- | -248.34%-71.75M | ---- | 2,386.79%48.37M | ---- | -50.26%1.95M |
Cash from business operations | ---- | 172.48%212.38M | ---- | -40.95%77.94M | ---- | -57.66%132M | ---- | 91.81%311.74M | ---- | -20.74%162.53M |
Other taxs | ---- | -465.27%-35.94M | ---- | 79.05%-6.36M | ---- | 5.10%-30.34M | ---- | 23.17%-31.98M | ---- | -85.19%-41.62M |
Special items of business | 6,337.52%44.22M | ---- | 99.11%-709K | ---- | -462.53%-79.33M | ---- | -58.11%21.88M | ---- | 7.08%52.23M | ---- |
Net cash from operations | 6,337.52%44.22M | 146.48%176.44M | 99.11%-709K | -29.58%71.58M | -462.53%-79.33M | -63.66%101.65M | -58.11%21.88M | 131.38%279.77M | 11.11%52.23M | -33.78%120.91M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 431.33%16.42M | -69.71%5.94M | -72.68%3.09M | 4.20%19.61M | 71.94%11.31M | -30.40%18.82M | -45.99%6.58M | 17.14%27.04M | 50.31%12.18M | 52.54%23.08M |
Loan receivable (increase) decrease | 582.37%4.24M | 103.09%640K | 97.66%-879K | 93.03%-20.7M | 86.44%-37.5M | -1,628.57%-296.79M | -15,509.48%-276.6M | -67.80%19.42M | -102.39%-1.77M | 146.02%60.3M |
Decrease in deposits (increase) | 962.63%1.05M | -114.57%-3.05M | -99.53%99K | 200.67%20.95M | 137.43%20.93M | -140.19%-20.81M | -207.91%-55.91M | 355.29%51.77M | 64.31%51.81M | -66.14%-20.28M |
Sale of fixed assets | ---- | 405.26%576K | ---- | -83.99%114K | ---- | -42.99%712K | ---- | 177.56%1.25M | ---- | 164.71%450K |
Purchase of fixed assets | 62.67%-44.95M | -478.71%-168.61M | -952.48%-120.43M | 37.50%-29.14M | 34.27%-11.44M | 67.05%-46.61M | 77.47%-17.41M | -207.89%-141.46M | -67.93%-77.27M | -11.10%-45.94M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.38M | --4.38M | ---- |
Purchase of intangible assets | 98.27%-520K | ---34.57M | ---30.07M | ---- | ---- | ---- | ---- | 69.21%-5.99M | ---5.98M | ---19.44M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --36M |
Acquisition of subsidiaries | ---- | 88.53%-2.18M | ---- | ---18.99M | ---- | ---- | ---- | ---- | ---6.8M | ---- |
Cash on investment | -7,582.00%-26.89M | 28.23%-15.46M | 96.50%-350K | ---21.54M | ---10M | ---- | ---- | 68.48%-34.2M | 90.60%-10.2M | -8,363.34%-108.5M |
Other items in the investment business | 264.66%970K | 1,652.22%3.15M | -45.82%266K | -86.16%180K | -67.59%491K | 103.68%1.3M | 104.95%1.52M | -173.07%-35.31M | -151.56%-30.6M | 1,124.35%48.33M |
Net cash from investment operations | 66.49%-49.68M | -331.28%-213.55M | -465.67%-148.27M | 85.58%-49.52M | 92.33%-26.21M | -203.59%-343.38M | -431.99%-341.82M | -335.02%-113.11M | -443.65%-64.25M | 87.35%-26M |
Net cash before financing | 96.34%-5.45M | -268.16%-37.11M | -41.16%-148.98M | 109.13%22.07M | 67.01%-105.54M | -245.04%-241.72M | -2,561.25%-319.94M | 75.60%166.66M | -118.30%-12.02M | 513.89%94.91M |
Cash flow from financing activities | ||||||||||
New borrowing | -27.16%360.2M | 13.45%741.99M | 0.81%494.49M | -11.98%654M | -3.63%490.5M | 26.15%743M | 17.01%509M | -15.79%589M | -8.32%435M | 29.67%699.46M |
Refund | -0.29%-310.23M | -11.86%-646.47M | 22.97%-309.32M | -8.66%-577.92M | -63.90%-401.56M | 19.19%-531.86M | 19.18%-245M | 3.50%-658.16M | 13.20%-303.16M | -39.19%-682.01M |
Interest paid - financing | -20.59%-17.1M | 6.31%-29.15M | 16.89%-14.18M | -13.11%-31.12M | -60.29%-17.06M | -23.74%-27.51M | 17.96%-10.65M | -10.90%-22.23M | 2.36%-12.98M | -20.62%-20.05M |
Dividends paid - financing | ---37.8M | -2.20%-18.21M | ---- | 65.54%-17.82M | ---- | -155.68%-51.7M | ---- | 44.39%-20.22M | ---- | 30.12%-36.36M |
Absorb investment income | --700K | -86.67%400K | ---- | -69.29%3M | ---- | 30.17%9.77M | 62.82%9.77M | --7.51M | --6M | ---- |
Other items of the financing business | -3.88%-3.11M | 60.17%-37.26M | 96.88%-2.99M | -6,242.71%-93.56M | -3,564.09%-95.93M | ---1.48M | -18.46%-2.62M | ---- | ---2.21M | ---- |
Net cash from financing operations | -104.37%-7.34M | 108.07%7.82M | 798.51%168M | -171.67%-96.86M | -109.23%-24.05M | 224.31%135.15M | 112.39%260.51M | -153.94%-108.72M | 11.48%122.66M | -122.33%-42.81M |
Effect of rate | -91.55%6K | -118.96%-924K | -76.33%71K | -620.99%-422K | 2,042.86%300K | -52.07%81K | 102.47%14K | -77.70%169K | -136.95%-566K | -67.20%758K |
Net Cash | -167.26%-12.8M | 60.83%-29.29M | 114.68%19.02M | 29.82%-74.79M | -118.05%-129.59M | -283.93%-106.57M | -153.72%-59.43M | 11.22%57.94M | -37.04%110.63M | 223.49%52.1M |
Begining period cash | -9.43%290.09M | -19.02%320.3M | -19.02%320.3M | -19.32%395.51M | -19.32%395.51M | 13.45%490.23M | 13.45%490.23M | 13.94%432.11M | 13.94%432.11M | -9.51%379.26M |
Cash at the end | -18.30%277.3M | -9.43%290.09M | 27.49%339.39M | -16.53%320.3M | -38.20%266.22M | -21.72%383.73M | -20.54%430.81M | 13.45%490.23M | -2.58%542.18M | 13.94%432.11M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.